Navigation Links
Experimental drug to fight flu

RECENT research has shown that new compounds developed for preventing and treating the flue have shown promise in animal studies, and may require only one dose to be effective.// The compounds, known collectively as multimeric zanamivir, are based on the existing flu drug relenza, or zanamivir, which the U.S. Food and Drug administration approved in 1999 for treating influenza A and B.

Researchers reported at the International Conference on Antiviral Research in Prague that a single dose of multimeric zanamivir successfully treated mice infected with human influenza A and B.


'"/>




Page: 1

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Experimental SARS Vaccine
3. Experimental vaccine for shingles is effective
4. Experimental Blood Test May Spot Heart Attack Risk, Study Says
5. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
6. Protection against HIV and Herpes is possible with the Experimental Microbicide
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Experimental Alzheimer’s Drug curbs the disease in mic
9. New Guidelines to Be Laid While Testing Experimental Drugs
10. Experimental Drug Deals Effectively with Prostate Cancer Cells
11. Experimental Drug Causes Cytokine Storm
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... Peruvian Ayahuasca retreat, ... be awarded annually to and divided between two full-time university students enrolled in ... Amazonian plant medicine. To apply for the scholarship, students are asked to submit ...
(Date:7/24/2017)... ... 24, 2017 , ... The Topricin Companies, formerly Topical Biomedics, ... revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. , ... skin conditions, including cancer. In the short term, overexposure to sun, wind ...
(Date:7/24/2017)... Switzerland (PRWEB) , ... July 24, 2017 , ... Anyone ... to weigh a watermelon, nor would a pharmacist using that same scale to dispense ... risk someone’s health. , These illustrations show why it is important to have ...
(Date:7/24/2017)... ... 2017 , ... Paul Vitenas, MD, FACS is excited to report that he ... attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the top ... bringing a newly defined structure to the aesthetics market. Dr. Vitenas , along ...
(Date:7/24/2017)... ... ... Summer storms are inevitable as weather temperatures in Philadelphia climb. These ... tree damage requiring emergency tree service. Giroud Tree and Lawn provides ... hazardous tree removal. , “A summer storm is like a bully on ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on the development of ... approval from the Israel Securities Authority to dual-list its common ... stock will commence trading on the TASE on July 12, ... capitalization of the Company, it is expected that Oramed will ...
(Date:7/5/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... announced that it has reached an agreement with WAVI ... to modify its existing credit facility effective June 30, ... agreed to exchange its existing $4.25 million credit facility, ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: